How I treat hemochromatosis.
Adams
Paul C
PC
University Hospital, University of Western Ontario, London, ON, Canada. padams@uwo.ca
Barton
James C
JC
D001782:Blood Donors; D015913:Chelation Therapy; D016238:Cytapheresis; D003676:Deferoxamine / Q000627:therapeutic use; D005260:Female; D006432:Hemochromatosis / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I / Q000235:genetics; D006720:Homozygote; D006801:Humans; D007501:Iron / Q000378:metabolism; D019266:Iron, Dietary / Q000008:administration & dosage; D008297:Male; D008565:Membrane Proteins / Q000235:genetics; D018962:Phlebotomy; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D017262:Siderophores / Q000627:therapeutic use
C103673:HFE protein, human; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D019266:Iron, Dietary; D008565:Membrane Proteins; D054328:Proton Pump Inhibitors; D017262:Siderophores; D007501:Iron; D003676:Deferoxamine